Case number 1:20-cv-01215
Intercept Pharmaceuticals, Inc. et al v. Optimus Pharma Pvt. Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 17, 2023 | 41 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 01/17/2023) (Consent Judgment) (3) |
| Jan 17, 2023 | 41 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 01/17/2023) (Main Document) (1) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Nov 9, 2021 | 40 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by R. Touhey Myer (Myer, R.) |
| Jul 8, 2021 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Jul 6, 2021 | 38 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for the Production of Documents and Things to Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. (Nos. 1-55); and 2) Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Mar 12, 2021 | 37 | SO ORDERED (5) Docket Text: SO ORDERED re (40 in 1:20-cv-01214-MN, 32 in 1:20-cv-01155-MN, 36 in 1:20-cv-01215-MN, 34 in 1:20-cv-01154-MN, 21 in 1:21-cv-00035-MN, 38 in 1:20-cv-01105-MN) Stipulation and Order to Consolidate. ALL FUTURE FILINGS SHALL BE MADE IN C.A. NO. 20-1105. Signed by Judge Maryellen Noreika on 3/12/2021. (dlw) |
| Mar 12, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-cv-01105-MN. (dlw) |
| Mar 10, 2021 | 36 | Stipulation (5) Docket Text: STIPULATION and Order to Consolidate by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Mar 9, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Having been advised by the parties of their inability to resolve protective order disputes, IT IS HEREBY ORDERED that a Telephone Conference is set for 4/13/2021 at 12:00 PM before Judge Maryellen Noreika. The opening letter, not to exceed three (3) pages, is due on or before 4/7/2021 and shall attach a copy of the proposed protective order setting forth Plaintiffs' and Defendants' positions. The responsive letter, not to exceed three (3) pages, is due on or before 4/8/2021. Counsel shall provide a dial-in number for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/9/2021. (dlw) |
| Mar 3, 2021 | 34 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Feb 26, 2021 | 33 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve) |
| Feb 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (37 in 1:20-cv-01214-MN, 31 in 1:20-cv-01154-MN, 17 in 1:21-cv-00035-MN, 32 in 1:20-cv-01105-MN, 33 in 1:20-cv-01215-MN, 29 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021. ORDERED by Judge Maryellen Noreika on 2/26/2021. (dlw) |
| Feb 22, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynges Judicial Administrator to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/22/21. Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak) |
| Feb 19, 2021 | 31 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Feb 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (35 in 1:20-cv-01214-MN, 27 in 1:20-cv-01155-MN, 30 in 1:20-cv-01105-MN, 31 in 1:20-cv-01215-MN, 29 in 1:20-cv-01154-MN, 15 in 1:21-cv-00035-MN) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021. ORDERED by Judge Maryellen Noreika on 2/19/2021. (dlw) |
| Feb 12, 2021 | 30 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve) |
| Feb 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (29 in 1:20-cv-01105-MN, 26 in 1:20-cv-01155-MN, 30 in 1:20-cv-01215-MN, 34 in 1:20-cv-01214-MN, 28 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021. ORDERED by Judge Maryellen Noreika on 2/12/2021. (dlw) |
| Feb 3, 2021 | 29 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Rule 26(A)(1); and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Feb 3, 2021 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Paragraph 3 Disclosures and Defendants' Rule 26(a)(1) Initial Disclosures filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.) |
| Jan 27, 2021 | 27 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2021. Amended Pleadings due by 9/10/2021. Fact Discovery completed by 5/30/2022. Opening Expert Reports due by 7/11/2022. Rebuttal Expert Reports due by 8/22/2022. Reply Expert Reports due by 9/26/2022. Daubert Motions due by 11/21/2022. Answering Brief due 12/12/2022. Reply Brief due 12/20/2022. Claim Construction Opening Brief served by 10/27/2021. Claim Construction Answering Brief served by 12/1/2021. Claim Construction Reply Brief served by 1/7/2022. Claim Construction Surreply Brief served by 1/28/2022. Joint Claim Construction Brief filed by 2/2/2022. A Markman Hearing is set for 3/4/2022 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 2/14/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 2/27/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 1/27/2021. (dlw) |
| Jan 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak) |
| Jan 22, 2021 | 26 | Proposed Order (15) Docket Text: PROPOSED ORDER // Scheduling Order by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 1/25/2021 (dlw). |
| Jan 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (25 in 1:20-cv-01215-MN, 28 in 1:20-cv-01214-MN, 23 in 1:20-cv-01154-MN, 21 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021. ORDERED by Judge Maryellen Noreika on 1/20/2021. (dlw) |
| Jan 19, 2021 | 25 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021 - filed by Apotex Corp., Apotex Inc.. (Belgam, Neal) |
| Jan 13, 2021 | 24 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Blumenfeld, Jack) |
| Jan 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01155-MN, 24 in 1:20-cv-01215-MN, 23 in 1:20-cv-01105-MN, 24 in 1:20-cv-01214-MN, 22 in 1:20-cv-01154-MN) MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 1/13/2021. (dlw) |
| Jan 11, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:20-cv-01155-MN, 22 in 1:20-cv-01105-MN, 23 in 1:20-cv-01215-MN, 23 in 1:20-cv-01214-MN, 21 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021. ORDERED by Judge Maryellen Noreika on 1/11/2021. (dlw) |
| Jan 11, 2021 | 23 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Dec 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01214-MN, 22 in 1:20-cv-01215-MN, 18 in 1:20-cv-01155-MN, 21 in 1:20-cv-01105-MN, 20 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021. ORDERED by Judge Maryellen Noreika on 12/22/2020. (dlw) |
| Dec 22, 2020 | 22 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Dec 15, 2020 | 21 | Answer to Counterclaim (10) Docket Text: ANSWER to [20] Answer to Amended Complaint, Counterclaim // Answer to Optimus Counterclaims by Intercept Pharma Europe Ltd., Intercept Pharmaceuticals, Inc. (Blumenfeld, Jack) Modified on 12/16/2020 (dlw). |
| Dec 1, 2020 | 20 | Answer to Amended Complaint (27) Docket Text: ANSWER to Amended Complaint, re: [17] Amended Complaint, Affirmative Defenses and COUNTERCLAIM against Intercept Pharma Europe Ltd., Intercept Pharmaceuticals, Inc. by Optimus Pharma Pvt. Ltd., Optimus Drugs Private Ltd. (Myer, R.) Modified on 12/2/2020 (dlw). |
| Dec 1, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed, coordinated order, including a proposal for the length and timing of trial, to the Court no later than thirty (30) days from the date of this Order. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 12/1/2020. (dlw) |
| Nov 20, 2020 | 18 | Patent/Trademark Report to Commissioner (1) Docket Text: Amended Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)RE48,286; 9,238,673; 10,047,117; 10,052,337; 10,174,073; 10,758,549. (Blumenfeld, Jack) Modified on 11/23/2020 (dlw). |
| Nov 20, 2020 | 17 | Exhibits A-G (524) |
| Nov 20, 2020 | 17 | Main Document (29) Docket Text: First AMENDED COMPLAINT against Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.- filed by Intercept Pharma Europe Ltd., Intercept Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-G)(Blumenfeld, Jack) |
| Nov 20, 2020 | 17 | Amended Complaint* (1) |
| Nov 17, 2020 | 16 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Optimus Pharma Pvt. Ltd.. (Myer, R.) |
| Nov 17, 2020 | 15 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Optimus Drugs Private Ltd.. (Myer, R.) |
| Nov 17, 2020 | 14 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIM against Intercept Pharma Europe Ltd., Intercept Pharmaceuticals, Inc. by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd. (Myer, R.) Modified on 11/17/2020 (dlw). |
| Nov 12, 2020 | 13 | SO ORDERED (13) Docket Text: SO ORDERED re [11] Stipulation to Substitute U.S. Patent No. RE48,286 for U.S. Patent No. 7,138,390. Signed by Judge Maryellen Noreika on 11/12/2020. (dlw) |
| Nov 11, 2020 | 12 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE48,286 E . (Blumenfeld, Jack) |
| Nov 11, 2020 | 11 | Exhibit A (11) |
| Nov 11, 2020 | 11 | Main Document (2) Docket Text: STIPULATION to Substitute U.S. Patent No. RE48,286 by Intercept Pharma Europe Ltd., Intercept Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Blumenfeld, Jack) |
| Sep 22, 2020 | 10 | Main Document (1) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd. (Attachments: # (1) Certificate of Service)(Myer, R.) |
| Sep 22, 2020 | 10 | Certificate of Service (1) |
| Sep 21, 2020 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.: For Optimus Pharma Pvt. Ltd. waiver sent on 9/18/2020, answer due 11/17/2020. (Blumenfeld, Jack) |
| Sep 21, 2020 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.: For Optimus Drugs Private Ltd. waiver sent on 9/18/2020, answer due 11/17/2020. (Blumenfeld, Jack) |
| Sep 16, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01214-MN, 1:20-cv-01215-MN (rjb) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe Limited and Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-UNA, 1:20-cv-01215-UNA(kmd) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (7 in 1:20-cv-01154-MN, 7 in 1:20-cv-01215-UNA, 7 in 1:20-cv-01214-UNA, 7 in 1:20-cv-01155-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited, Intercept Pharma Europe Ltd. ORDERED by Judge Maryellen Noreika on 9/15/2020. (dlw) |
| Sep 14, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Sep 11, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (amf) |
| Sep 10, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intercept Pharmaceuticals, Inc. for Intercept Pharma Europe Ltd. - filed by Intercept Pharma Europe Ltd. and Intercept Pharmaceuticals, Inc. (amf) |
| Sep 10, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; 7,138,390 B2. (amf) |
| Sep 10, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/28/20. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 11/27/2023. (amf) |
| Sep 10, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Sep 10, 2020 | 1 | Civil Cover Sheet (1) |
| Sep 10, 2020 | 1 | Complaint* (1) |
| Sep 10, 2020 | 1 | Exhibits A-F (415) |
| Sep 10, 2020 | 1 | Main Document (24) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number ADEDC-3191862) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd. (Attachments: # (1) Exhibits A-F, # (2) Civil Cover Sheet)(amf) |
